Details for Australian Trade Mark No. 1046177 (hide)

Owner American Express Marketing & Development Corp.

Convention EM 23 NOVEMBER 2004 4145645

IR Number 842362

Filing Date 23 December 2004

Classes

Class 5 Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders including Crohn's diseases, all o f t h e a b o v e e x c l u d i n g t h e t r e a t m e n t o f gastrointestinal problems and diseases

Event Publications

14 April 2005 Application filed

14 April 2005 Application Accepted

11 August 2005 Trade Mark Registered/Protected

22 December 2005 Subsequent Owners/Holder Registered - Full Assignment

  Genentech Espana, S.L. is the full asignee of Genentech Inc..

23 October 2008 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to American Express Marketing & Development Corp..

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1046178-SPRING VALLEY

1046176